Literature DB >> 28577758

Diagnosis of recurrent venous thromboembolism.

Stefano Barco1, Stavros Konstantinides1, Menno V Huisman2, Frederikus A Klok3.   

Abstract

The diagnostic management of suspected recurrent venous thromboembolism (VTE) is challenging for four main reasons. First, clinical decision rules are less useful to identity patients with a low pre-test probability. Second, the diagnostic performance of D-dimer tests is decreased. Together, these two point lead to a clearly lower proportion of patients in whom recurrent VTE can be ruled out without performing imaging tests. Third, recurrent thrombi may be difficult to differentiate from residual thrombi, which may be often identified in patients with a history of VTE. Fourth and lastly, the prevalence of VTE in patients with suspected recurrent disease is higher than in patients with suspected first VTE. As a consequence, the failure rates of the algorithms in patients with suspected recurrent VTE are higher as well, underling the relevance of accurate diagnostic management of this specific patient population. There is a lack of large well designed diagnostic studies that focus mainly on patients with prior VTE. Even so, available evidence suggests that diagnostic algorithms validated for first VTE are also largely applicable to suspected recurrent VTE. Emerging imaging techniques such as magnetic resonance direct thrombus imaging (MRDTI) are likely to improve the accuracy of the algorithms in the near future.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep vein thrombosis; Diagnosis; Pulmonary embolism; Recurrence

Mesh:

Year:  2017        PMID: 28577758     DOI: 10.1016/j.thromres.2017.05.026

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry.

Authors:  Yugo Yamashita; Takeshi Morimoto; Frederikus A Klok; Stefano Barco; Yuji Nishimoto; Takao Kato; Koh Ono; Takeshi Kimura
Journal:  J Thromb Thrombolysis       Date:  2022-06-17       Impact factor: 5.221

2.  Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis.

Authors:  Lisette F van Dam; Wilbert B van den Hout; Gargi Gautam; Charlotte E A Dronkers; Waleed Ghanima; Jostein Gleditsch; Anders von Heijne; Herman M A Hofstee; Marcel M C Hovens; Menno V Huisman; Stan Kolman; Albert T A Mairuhu; Mathilde Nijkeuter; Marcel A van de Ree; Cornelis J van Rooden; Robin E Westerbeek; Jan Westerink; Eli Westerlund; Lucia J M Kroft; Frederikus A Klok
Journal:  Blood Adv       Date:  2021-03-09

3.  Safety of using the combination of the Wells rule and D-dimer test for excluding acute recurrent ipsilateral deep vein thrombosis.

Authors:  Lisette F van Dam; Gargi Gautam; Charlotte E A Dronkers; Waleed Ghanima; Jostein Gleditsch; Anders von Heijne; Herman M A Hofstee; Marcel M C Hovens; Menno V Huisman; Stan Kolman; Albert T A Mairuhu; Mathilde Nijkeuter; Marcel A van de Ree; Cornelis J van Rooden; Robin E Westerbeek; Jan Westerink; Eli Westerlund; Lucia J M Kroft; Frederikus A Klok
Journal:  J Thromb Haemost       Date:  2020-07-21       Impact factor: 5.824

4.  Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis.

Authors:  Synne G Fronas; Camilla T Jørgensen; Anders E A Dahm; Hilde S Wik; Jostein Gleditsch; Nezar Raouf; René Holst; F A Klok; Waleed Ghanima
Journal:  Blood Adv       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.